Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomes

Kessler, 2005, Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication, Arch Gen Psychiatry, 62, 617, 10.1001/archpsyc.62.6.617 Mrazek, 2014, A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013, Psychiatr Serv, 65, 977, 10.1176/appi.ps.201300059 Nemeroff, 2007, Prevalence and management of treatment-resistant depression, J Clin Psychiatry, 68, 17 Rush, 2006, Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, 163, 1905, 10.1176/ajp.2006.163.11.1905 Krishnan, 2008, The molecular neurobiology of depression, Nature, 455, 894, 10.1038/nature07455 Giacobbe, 2009, Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation, Exp Neurol, 219, 44, 10.1016/j.expneurol.2009.04.028 Mayberg, 2003, Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment, Br Med Bull, 65, 193, 10.1093/bmb/65.1.193 Mayberg, 2005, Deep brain stimulation for treatment-resistant depression, Neuron, 45, 651, 10.1016/j.neuron.2005.02.014 Bewernick, 2010, Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression, Biol Psychiatry, 67, 110, 10.1016/j.biopsych.2009.09.013 Holtzheimer, 2012, Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression, Arch Gen Psychiatry, 69, 150, 10.1001/archgenpsychiatry.2011.1456 Schlaepfer, 2013, Rapid effects of deep brain stimulation for treatment-resistant major depression, Biol Psychiatry, 73, 1204, 10.1016/j.biopsych.2013.01.034 Malone, 2009, Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression, Biol Psychiatry, 65, 267, 10.1016/j.biopsych.2008.08.029 Holtzheimer, 2017, Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial, Lancet Psychiatry, 4, 839, 10.1016/S2215-0366(17)30371-1 Dougherty, 2015, A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression, Biol Psychiatry, 78, 240, 10.1016/j.biopsych.2014.11.023 Bari, 2018, Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders, J Neurol Neurosurg Psychiatry, 89, 886, 10.1136/jnnp-2017-317082 Schlaepfer, 2015, Deep brain stimulation for major depression—steps on a long and winding road, Biol Psychiatry, 78, 218, 10.1016/j.biopsych.2015.06.020 Fins, 2017, Being open minded about neuromodulation trials: finding success in our “failures”, Brain Stimul, 10, 181, 10.1016/j.brs.2016.12.012 Filkowski, 2019, Deep brain stimulation for depression: an emerging indication, Neurosurg Clin N Am, 30, 243, 10.1016/j.nec.2018.12.007 2020, Measuring success: the problem with primary outcomes, Lancet Psychiatry, 7, 1, 10.1016/S2215-0366(19)30483-3 Bewernick, 2017, Deep brain stimulation to the medial forebrain bundle for depression—long-term outcomes and a novel data analysis strategy, Brain Stimul, 10, 664, 10.1016/j.brs.2017.01.581 Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 382, 10.1192/bjp.134.4.382 Rush, 1986, The Inventory for Depressive Symptomatology (IDS): preliminary findings, Psychiatry Res, 18, 65, 10.1016/0165-1781(86)90060-0 Rosenblat, 2019, Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression, J Affect Disord, 243, 116, 10.1016/j.jad.2018.09.027 Zimmerman, 2006, Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined, Psychiatry Res, 141, 185, 10.1016/j.psychres.2005.05.016 Schlaepfer, 2008, Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression, Neuropsychopharmacology, 33, 368, 10.1038/sj.npp.1301408 Holtzheimer, 2011, Stuck in a rut: rethinking depression and its treatment, Trends Neurosci, 34, 1, 10.1016/j.tins.2010.10.004 Widge, 2019, Deep brain stimulation of the internal capsule enhances human cognitive control and prefrontal cortex function, Nat Commun, 10, 10.1038/s41467-019-09557-4 Dandekar, 2018, Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications, Mol Psychiatry, 23, 1094, 10.1038/mp.2018.2 Widge, 2016, Deep brain stimulation for treatment-resistant psychiatric illnesses: what has gone wrong and what should we do next?, Biol Psychiatry, 79, e9, 10.1016/j.biopsych.2015.06.005 Widge, 2018, Closing the loop on deep brain stimulation for treatment-resistant depression, Front Neurosci, 12, 175, 10.3389/fnins.2018.00175 Blaney, 1986, Affect and memory: a review, Psychol Bull, 99, 229, 10.1037/0033-2909.99.2.229 Masson, 2013, Minimum clinically important differences identified for commonly used depression rating scales, J Clin Epidemiol, 66, 805, 10.1016/j.jclinepi.2013.01.010 Hobart, 2007, Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations, Lancet Neurol, 6, 1094, 10.1016/S1474-4422(07)70290-9 Kelley, 2012, The Illness Density Index (IDI): a longitudinal measure of treatment efficacy, Clin Trials, 9, 596, 10.1177/1740774512450099 Greenberg, 2006, Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder, Neuropsychopharmacology, 31, 2384, 10.1038/sj.npp.1301165 de Haan, 2015, Effects of deep brain stimulation on the lived experience of obsessive-compulsive disorder patients: in-depth interviews with 18 patients, PLoS One, 10, 10.1371/journal.pone.0135524 Schlaepfer, 2008, Vagus nerve stimulation for depression: efficacy and safety in a European study, Psychol Med, 38, 651, 10.1017/S0033291707001924 Lopes, 2014, Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial, JAMA Psychiatry, 71, 1066, 10.1001/jamapsychiatry.2014.1193 Sheth, 2013, Limbic system surgery for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients, J Neurosurg, 118, 491, 10.3171/2012.11.JNS12389 Widge, 2017, Treating refractory mental illness with closed-loop brain stimulation: progress towards a patient-specific transdiagnostic approach, Exp Neurol, 287, 461, 10.1016/j.expneurol.2016.07.021 Cohen, 2013, Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD, JAMA Psychiatry, 70, 343, 10.1001/jamapsychiatry.2013.286 Zimmerman, 2006, How should remission from depression be defined? The depressed patient's perspective, Am J Psychiatry, 163, 148, 10.1176/appi.ajp.163.1.148 IsHak, 2011, Quality of life: the ultimate outcome measure of interventions in major depressive disorder, Harv Rev Psychiatry, 19, 229, 10.3109/10673229.2011.614099 Giacobbe, 2018, Improvements in health-related quality of life with electroconvulsive therapy: a meta-analysis, J ECT, 34, 87, 10.1097/YCT.0000000000000486 Crawford, 2002, Evaluating new treatments in psychiatry: the potential value of combining qualitative and quantitative research methods, Int Rev Psychiatry, 14, 6, 10.1080/09540260120114005 Bosanac, 2018, Identity challenges and ‘burden of normality’ after DBS for severe OCD: a narrative case study, BMC Psychiatry, 18, 186, 10.1186/s12888-018-1771-2 Illes, 2011, Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition, Stem Cell Rev Rep, 7, 997, 10.1007/s12015-011-9259-1 Kubu, 2017, Insights gleaned by measuring patients' stated goals for DBS: more than tremor, Neurology, 88, 124, 10.1212/WNL.0000000000003485 Kubu, 2012, Beyond mere symptom relief in deep brain stimulation: an ethical obligation for multi-faceted assessment of outcome, AJOB Neurosci, 3, 44, 10.1080/21507740.2011.633960 Nahum, 2017, Immediate mood scaler: tracking symptoms of depression and anxiety using a novel mobile mood scale, JMIR Mhealth Uhealth, 5, e44, 10.2196/mhealth.6544 Armey, 2015, Ecological momentary assessment (EMA) of depression-related phenomena, Curr Opin Psychol, 4, 21, 10.1016/j.copsyc.2015.01.002 Schaffer, 2013, Use of mental health telemetry to enhance identification and predictive value of early changes during augmentation treatment of major depression, J Clin Psychopharmacol, 33, 775, 10.1097/JCP.0b013e31829e8359 Richmond, 2015, Feasibility, acceptability and validity of SMS text messaging for measuring change in depression during a randomised controlled trial, BMC Psychiatry, 15, 68, 10.1186/s12888-015-0456-3 Rao, 2018, Direct electrical stimulation of lateral orbitofrontal cortex acutely improves mood in individuals with symptoms of depression, Curr Biol, 28, 3893, 10.1016/j.cub.2018.10.026 Insel, 2017, Digital phenotyping: technology for a new science of behavior, JAMA, 318, 1215, 10.1001/jama.2017.11295 Hsin, 2018, Transforming psychiatry into data-driven medicine with digital measurement tools, NPJ Digit Med, 1, 37, 10.1038/s41746-018-0046-0 Dogan, 2017, Smartphone-based monitoring of objective and subjective data in affective disorders: where are we and where are we going? Systematic review, J Med Internet Res, 19, e262, 10.2196/jmir.7006 Lo, 2017, Closed-loop neuromodulation systems: next-generation treatments for psychiatric illness, Int Rev Psychiatry, 29, 191, 10.1080/09540261.2017.1282438 Sun, 2014, Closed-loop neurostimulation: the clinical experience, Neurotherapeutics, 11, 553, 10.1007/s13311-014-0280-3 Cagnan, 2019, Emerging technologies for improved deep brain stimulation, Nat Biotechnol, 37, 1024, 10.1038/s41587-019-0244-6 Krook-Magnuson, 2015, Neuroelectronics and biooptics: closed-loop technologies in neurological disorders, JAMA Neurol, 72, 823, 10.1001/jamaneurol.2015.0608 Sani, 2018, Mood variations decoded from multi-site intracranial human brain activity, Nat Biotechnol, 36, 954, 10.1038/nbt.4200 Kirkby, 2018, An amygdala-hippocampus subnetwork that encodes variation in human mood, Cell, 175, 1688, 10.1016/j.cell.2018.10.005 Bergfeld, 2016, Deep brain stimulation of the ventral anterior limb of the internal capusule for treatment-resistant depression: a randomized clinical trial, JAMA Psychiatry, 73, 456, 10.1001/jamapsychiatry.2016.0152 Wright, 2018, When biomarkers are not enough: FDA evaluation of effectiveness of neuropsychiatric devices for disorders of consciousness, Stanf Technol Law Rev, 21, 276